Xu L - Search Results

1

Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study.

Chen X, Wang H, Sun X, Su L, Liu F, Zhao K, Xu L, Wu S, Song T. Chen X, et al. Among authors: xu l. Ann Transl Med. 2021 Dec;9(24):1769. doi: 10.21037/atm-21-6019. Ann Transl Med. 2021. PMID: 35071463 Free PMC article.

2

Critical involvement of the α(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia.

Che Y, Ren X, Xu L, Ding X, Zhang X, Sun X. Che Y, et al. Among authors: xu l. Oncol Rep. 2016 May;35(5):3025-33. doi: 10.3892/or.2016.4673. Epub 2016 Mar 11. Oncol Rep. 2016. PMID: 26986216

3

Successful treatment of a rare subcutaneous panniculitis-like T-cell lymphoma: An unusual case report and literature review.

Xu L, Che Y, Ding X, Song J, Zhang X, Sun X. Xu L, et al. Dermatol Ther. 2019 May;32(3):e12878. doi: 10.1111/dth.12878. Epub 2019 Apr 3. Dermatol Ther. 2019. PMID: 30884048 Review. No abstract available.

4

Effective remission of chidamide on treatment of advanced mycosis fungoides: An unusual case report.

Che Y, Ding X, Song J, Zhang X, Sun X, Xu L. Che Y, et al. Among authors: xu l. Dermatol Ther. 2019 Jul;32(4):e12944. doi: 10.1111/dth.12944. Epub 2019 May 2. Dermatol Ther. 2019. PMID: 31012254

5

Secondary hemophagocytic lymphohistiocytosis triggered by peripheral T-cell lymphoma: An unusual case report.

Che Y, Xu L, Zhang X, Qiu X, Song J, Ding X, Sun X. Che Y, et al. Among authors: xu l. Clin Case Rep. 2022 Nov 19;10(11):e6528. doi: 10.1002/ccr3.6528. eCollection 2022 Nov. Clin Case Rep. 2022. PMID: 36415711 Free PMC article.

6

Advances in the treatment of Hodgkin's lymphoma (Review).

Che Y, Ding X, Xu L, Zhao J, Zhang X, Li N, Sun X. Che Y, et al. Among authors: xu l. Int J Oncol. 2023 May;62(5):61. doi: 10.3892/ijo.2023.5509. Epub 2023 Apr 7. Int J Oncol. 2023. PMID: 37026506 Free PMC article. Review.

7

Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway.

Zhao X, Xu M, Hu X, Ding X, Zhang X, Xu L, Li L, Sun X, Song J. Zhao X, et al. Among authors: xu l, xu m. Stem Cell Res Ther. 2023 May 29;14(1):148. doi: 10.1186/s13287-023-03373-w. Stem Cell Res Ther. 2023. PMID: 37248542 Free PMC article.

8

Partial remission with sintilimab monotherapy in a patient carrying a CD274 amplification in refractory diffuse large B‑cell lymphoma: A case report.

Zhang X, Xu L, Pan E, Sun X, Ding X. Zhang X, et al. Among authors: xu l. Oncol Lett. 2024 Apr 30;27(6):289. doi: 10.3892/ol.2024.14423. eCollection 2024 Jun. Oncol Lett. 2024. PMID: 38736746 Free PMC article.

9

Richter's syndrome of the central nervous system diagnosed concurrently with chronic lymphocytic leukaemia: A case report and literature review.

Xu L, Song JC, Sun XH, Gao ZF, Lv L, Zhu J. Xu L, et al. Medicine (Baltimore). 2018 Oct;97(41):e12701. doi: 10.1097/MD.0000000000012701. Medicine (Baltimore). 2018. PMID: 30313065 Free PMC article.

10

Electrochemical reduction for chlorinated hydrocarbons contaminated groundwater remediation: Mechanisms, challenges, and perspectives.

Yu D, Jiang Q, Zhu H, Chen Y, Xu L, Ma H, Pu S. Yu D, et al. Among authors: xu l. Water Res. 2025 Jan 15;274:123149. doi: 10.1016/j.watres.2025.123149. Online ahead of print. Water Res. 2025. PMID: 39854779 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,117 results

Search Page

Filters